Answers are grounded in this paper and cite their sources.
Background Enoyl-CoA hydratase 1 deficiency (ECHS1D) is a rare mitochondrial disorder with marked clinical and genetic heterogeneity. However, genotype-phenotype correlations and functional consequences of many variants remain insufficiently characterized, particularly in East Asian populations. Methods We investigated 18 Chinese patients with ECHS1 deficiency. Genetic findings were examined alongside functional measurements in patient-derived lymphoblastoid cell lines and engineered cellular models, including ECHS1 protein abundance, crotonyl-CoA hydratase activity, and mitochondrial respiration. Results The cohort showed a broad clinical spectrum, including developmental impairment and Leigh-like neuroimaging abnormalities. Patient-derived cell lines showed reduced steady-state ECHS1 protein abundance, decreased crotonyl-CoA hydratase activity, and impaired mitochondrial respiration. Engineered models showed variant-dependent differences in protein abundance and hydratase activity, supporting their pathogenicity. Conclusions This study expands the genetic and clinical spectrum of ECHS1D in a Chinese cohort and provides integrated functional validation of disease-associated variants. Our findings highlight the complexity of genotype-phenotype relationships and suggest that ECHS1D may involve broader metabolic dysregulation than previously appreciated. These results support the incorporation of functional assays into variant interpretation and may improve diagnostic and clinical stratification in mitochondrial disease.
No takes yet. Share an insight, caveat, or question.
Zhou et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: